Removal and transformation of pharmaceuticals in wastewater treatment plants and constructed wetlands
Related subject area
Substances: Emerging chemical contaminants (endocrine disrupting compounds)
Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D., and Snyder, S. A.: Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water, Environ. Sci. Technol., 43, 597–603, 2009.
Conkle, J. L., White, J. R., and Metcalf, C. D.: Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana, Chemosphere, 73, 1741–1748, 2008.
Göbel, A., Thomsen, A., McArdell, C. A., Joss, A., and Giger, W.: Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment, Environ. Sci. Technol., 39, 3981–3989, 2005.
Heimstad, E. S., Bastos, P. M., Eriksson, J., Bergman, A., and Harju, M.: Quantitative structure – Photodegradation relationships of polybrominated diphenyl ethers, phenoxyphenols and selected organochlorines, Chemosphere, 77, 914–921, 2009.
Horikoshi, S., Tokunaga, A., Hidaka, H., and Serpone, N.: Environmental remediation by an integrated microwave/UV illumination method: VII. Thermal/non-thermal effects in the microwave-assisted photocatalyzed mineralization of bisphenol-A, J. Photoch. Photobio. A, 162, 33–40, 2004.